Project Grant R01DA064340
Award Date 9/30/25
Completion Date 5/31/30
Dollars Obligated $620K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $305,369 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Taesun, LLC in Colorado. The grant, with a period of performance from August 1, 2025 to January 31, 2026, is for the development of a comprehensive device that integrates fentanyl test strips with sample preparation features to enable convenient and discreet fentanyl testing in high-risk environments....
- This Project Grant award of $587,188.00 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports a multi-omics research study on the impact of fentanyl use on cells susceptible to HIV infection. The research aims to evaluate the effects of fentanyl on the single-cell transcriptome and microRNA profiles in various peripheral blood mononuclear cell types, including CD4+ and CD8+ T lymphocytes, monocytes, B lymphocytes, dendritic...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $193,250 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the Trustees of Tufts College, doing business as Tufts University School of Medicine in Boston, Massachusetts. The grant, awarded on September 15, 2025, aims to determine whether fentanyl overdose induces an anhedonic phenotype, which in turn increases the risk of relapse in individuals with opioid use...
- The San Francisco Department of Public Health (SFDPH) was awarded a $1,600,000 Project Grant by the Bureau of Justice Assistance (BJA) under the Comprehensive Opioid, Stimulant, and other Substances Use Program (CFDA 16.838). The grant will fund the implementation of the "Data-Driven Health Systems Change for Prevention" (DHSCP) program, which aims to develop a comprehensive, collaborative, and innovative Overdose Fatality Review (OFR) process in San Francisco. Key expected outcomes...
- This Project Grant award of $1,573,958 from the National Institute on Drug Abuse (NIDA), part of the Drug Use and Addiction Research Programs (CFDA 93.279), is focused on identifying individuals who are viremic and/or have substance use disorder (SUD) to engage them for early intervention. The project will implement routine SUD screening using the NIDA Quick Screen and a social network intervention to find individuals who are viremic, have SUD, or both, and link them to harm reduction and HIV...
- This federal Project Grant award of $272,395.00 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports research to develop methods for targeting the G9A and GLP enzymes, which are involved in the development of addictive behaviors to stimulants and opioids. The research aims to better understand the molecular functions of G9A and GLP in the addiction process and explore therapeutic approaches that do not rely on catalytic site...
- This federal Project Grant award of $769,708 from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), is for the "Drug Use and Addiction Research Programs" (CFDA 93.279). The award supports research to adapt and pilot test the Brief Negotiation Interview (BNI) for use among assault-injured emerging adults (ages 18-25) with alcohol and/or cannabis misuse who seek care in the emergency department setting. Key objectives include eliciting shared...
- This federal Project Grant award for $188,995.00 was provided by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), under the Drug Use and Addiction Research Programs (CFDA 93.279). The award supports research at the University of Pittsburgh focused on understanding, preventing, and treating substance use disorders. The project aims to develop novel interventions, explore neuroscientific mechanisms of addiction, and improve treatment strategies. The...
- This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $973,442 to The Regents of the University of California, San Francisco (UCSF) to develop and deliver a digital substance use prevention tool for foster youth. The project, titled "CASA AND FOSTRSPACE: SYSTEMS DELIVERY OF DIGITAL SUBSTANCE USE PREVENTION TOOLS TO FOSTER YOUTH," aims to address the higher rates of substance use...
- This Project Grant award of $1,607,146.00 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports the development of a technology-based intervention to encourage drug checking, distribution of harm reduction supplies, and linkage to services for people who use drugs. The project, titled "Together Against Overdose: Community Developed Technology to Encourage Drug Checking, Distribution of Harm Reduction Supplies, and...
This Project Grant award of $620,164 was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The grant will fund the "BEHAVIORAL SAFETY AND FENTANYL EDUCATION: BSAFE" project, which aims to adapt a successful opioid overdose prevention intervention to address unintentional fentanyl use among people who use stimulants. The project will test the adapted "B-SAFE" intervention against usual care through a randomized controlled trial of 160 participants over 16 months. If proven effective, the San Francisco Department of Public Health is positioned to continue providing the service. The award was made on September 30, 2025 with an ultimate completion date of May 31, 2030.
Generated 10/21/25, 5:55 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $620.2k | 9/23/25 |